Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Lantern Pharma Inc. (LTRN) had Weighted-Average Shares Outstanding (Diluted) of 10.76M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-20.78M |
|
-- |
|
-- |
|
$22.22M |
|
$-22.22M |
|
$1.44M |
|
$-20.78M |
|
$-20.78M |
|
$-20.78M |
|
$-20.78M |
|
$-20.78M |
|
$-20.78M |
|
$-22.22M |
|
$-22.44M |
|
10.76M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
10.76M |
$-1.93 |
|
$-1.93 |
|
| Balance Sheet Financials | |
$25.25M |
|
$0.05M |
|
$0.32M |
|
$25.57M |
|
$4.33M |
|
-- |
|
$0.05M |
|
$4.38M |
|
$21.19M |
|
$21.19M |
|
$21.19M |
|
10.79M |
|
| Cash Flow Statement Financials | |
$-17.81M |
|
$3.37M |
|
$0.07M |
|
$21.94M |
|
$7.51M |
|
$-14.43M |
|
$0.73M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.83 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-17.83M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-98.08% |
|
-98.08% |
|
-81.27% |
|
-98.08% |
|
$1.96 |
|
$-1.66 |
|
$-1.66 |
|